Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders

Schizophr Res. 2005 Dec 1;80(1):131-3. doi: 10.1016/j.schres.2005.07.024. Epub 2005 Sep 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use
  • Body Mass Index
  • Cholesterol, HDL / metabolism*
  • Cholesterol, LDL / metabolism*
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperlipidemias / chemically induced*
  • Male
  • Olanzapine
  • Prospective Studies
  • Psychotic Disorders / drug therapy*
  • Weight Gain*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Benzodiazepines
  • Olanzapine